TG Therapeutics Inc
(STU:NKB2)
€
49.4
+2.6 (+5.56%)
Market Cap: 7.52 Bil
Enterprise Value: 7.44 Bil
PE Ratio: 18.75
PB Ratio: 14.08
GF Score: 82/100 TG Therapeutics Inc (STU:NKB2) Transcripts
- 1